Cover storyPharma Manufacturing Trends 2026: From Smart Factories To AI-Driven Production
Pharma manufacturing trends in 2026 reveal smart factories, real-time AI quality checks, and predictive maintenance reshaping drug production
Cover storyPharma manufacturing trends in 2026 reveal smart factories, real-time AI quality checks, and predictive maintenance reshaping drug production

Harrow acquires global TYRVAYA rights from Viatris, triggering multi-jurisdiction regulatory transfers across U.S., China, Taiwan, and pending MAA markets.

Tarsus acquires Alkeus, adding Phase 3 gildeuretinol for Stargardt disease and triggering GMP scale-up and NDA strategy work.

Allergan Aesthetics files sNDA with FDA to expand BOTOX Cosmetic labeling to include a jawline contouring indication.

Lexicon's ZYNQUISTA NDA resubmission nears completion as STENO1 safety data approach FDA-defined thresholds; Q4 2026 filing targeted.
Latest edition
Aug 12
Sep 28From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.








Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.
